"We have established potencies or activities against MYC that are unprecedented," Dr Hopkins says.
"We are now embarking on a very aggressive transition from being perceived as a platform technology to applying that to very specific areas of need, specifically focused on cancer, around these high-value targets that no-one else has been able to touch before and which stretch across just about every type of cancer."
Bullish language from Dr Hopkins…
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |